Clinical Trials Directory

Trials / Completed

CompletedNCT06492239

Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-A )

Emergency Stroke Unit for Acute Cerebrovascular Events--A Prospective, Multicenter, Week-wise Randomized, Controlled Trial ( ESU-ACE-A )

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
218 (actual)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the door-to-needle time of patients with hyperacute ischemic stroke (within 4.5 hours after the onset of symptoms) managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).

Detailed description

Intravenous thrombolysis is an effective reperfusion therapy for patients with acute ischemic stroke. Faster door-to-needle time (DNT) is associated with significantly better clinical outcomes. With the development of low-field magnetic resonance imaging, it is poised to play an increasingly significant role in the early diagnosis and management of acute ischemic stroke. This prospective, multicenter, week-wise randomized controlled trial will compare the door-to-needle time of patients with hyperacute ischemic stroke (within 4.5 hours after the onset of symptoms) managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit (a new stroke unit based on low-field magnetic resonance imaging).

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTEmergency Stroke Unit based on 0.23-T MRIThe participants with hyperacute ischemic stroke (symptoms onset ≤4.5 h) who are eligible to receive reperfusion therapy will be managed by Emergency Stroke Unit process based on low-field magnetic resonance imaging.
COMBINATION_PRODUCTStandard stroke unit adherent to guidelinesThe participants with hyperacute ischemic stroke (symptoms onset ≤4.5 h) who are eligible to receive reperfusion therapy will be managed by standard stroke unit process adherent to guidelines.

Timeline

Start date
2024-07-26
Primary completion
2025-01-31
Completion
2025-01-31
First posted
2024-07-09
Last updated
2025-03-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06492239. Inclusion in this directory is not an endorsement.